Pediatric Pulmonary Spec is categorized under Pediatricians in Tampa, FL and active since 2010.
Pediatric Pulmonary Spec was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pediatricians business, which does work in the B2C market, and is classified as a Pediatricians, under code number 6212100 by the NAICS.
If you are seeking more information, feel free to contact David Rosenberg at the company’s single location by writing to 4714 North Armenia Avenue # 201, Tampa, Florida FL 33603 or by phoning (813) 870-1995. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pediatric Pulmonary Spec |
Contact Person: | David Rosenberg |
Address: | 4714 North Armenia Avenue # 201, Tampa, Florida 33603 |
Phone Number: | (813) 870-1995 |
Website Address: | pediatricpulmonaryspecialists.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Pediatricians |
SIC Code: | 8011 |
NAICS Code: | 6212100 |
Share This Business: |
Pediatric Pulmonary Spec was started in 2010 to provide professional Pediatricians under the SIC code 8011 and NAICS code 6212100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Rosenberg for inquiries that concern Pediatric Pulmonary Spec by calling the company number (813) 870-1995, as your correspondence is most welcome. Additionally, the physical location of the single location of Pediatric Pulmonary Spec can be found at the coordinates 27.98808,-82.48462 as well as the street address 4714 North Armenia Avenue # 201 in Tampa, Florida 33603.
For its online presence, you may visit Pediatric Pulmonary Spec’s website at pediatricpulmonaryspecialists.com and engage with its social media outlets through on Twitter and on Facebook.